Bempegaldesleukin (NKTR-214): a CD-122-biased IL-2 receptor agonist for cancer immunotherapy

Doberstein, SK

Doberstein, SK (reprint author), Nektar Therapeut, San Francisco, CA 94158 USA.

EXPERT OPINION ON BIOLOGICAL THERAPY, 2019; 19 (12): 1223

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索